Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Blood|November 17, 2010
BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: a report from the Children's Oncology GroupKara M Kelly, Richard Sposto, Raymond Hutchinson, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 13, 2002
Etanercept (Enbrel) administration for idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantationGregory Yanik, Beth Hellerstedt, Joseph Custer, et al.Ethics & Human Research|July 8, 2022
Perspectives from a Predominantly African American Community about Biobank Research and a Biobank Consent FormLaura K Sedig, E Hill De Loney, Sarah B Bailey, et al.Pediatric Blood & Cancer|October 4, 2021
Palliative care is not associated with decreased intensity of care: Results of a chart review from a large children's hospitalLaura K Sedig, Jessica L Spruit, Jessica Southwell, et al.Scientific Reports|June 17, 2020
A Metabolomics Approach for Early Prediction of Vincristine-Induced Peripheral NeuropathyParul Verma, Jayachandran Devaraj, Jodi L Skiles, et al.The Journal of Clinical Investigation|May 8, 2002
Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host diseaseRainer Ordemann, Raymond Hutchinson, Jeffrey Friedman, et al.Pediatric Blood & Cancer|June 29, 2010
Phase I study of bortezomib combined with chemotherapy in children with relapsed childhood acute lymphoblastic leukemia (ALL): a report from the therapeutic advances in childhood leukemia (TACL) consortiumYoav Messinger, Paul Gaynon, Elizabeth Raetz, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 26, 2003
Lowered-intensity preparative regimen for allogeneic stem cell transplantation delays acute graft-versus-host disease but does not improve outcome for advanced hematologic malignancyJohn E Levine, Joseph P Uberti, Lois Ayash, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 2009
Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium studyRichard H Ko, Lingyun Ji, Phillip Barnette, et al.Clinical Pharmacology and Therapeutics|December 4, 2018
Genetic Variants Associated With Vincristine-Induced Peripheral Neuropathy in Two Populations of Children With Acute Lymphoblastic LeukemiaLang Li, Tammy Sajdyk, Ellen M L Smith, et al.Pageof 4